Huntington National Bank Invitae Corp Transaction History

Huntington National Bank

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 21, 2022	SELL	$14.7 - $28.67 $11,025 - $21,502	-750 Closed	0 $0
Q3 2021 Oct 28, 2021	SELL	$24.31 - $33.6 $11,231 - $15,523	-462 Reduced 38.12%	750 $21,000
Q2 2021 Jul 30, 2021	BUY	$26.09 - $40.4 $12,053 - $18,664	462 Added 61.6%	1,212 $41,000
Q4 2020 Jan 11, 2021	BUY	$39.09 - $57.4 $5,863 - $8,610	150 Added 25.0%	750 $31,000
Q2 2020 Jul 30, 2020	BUY	$11.71 - $30.29 $7,026 - $18,174	600 New	600 $18,000

7.66M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Huntington National Bank, based on Form 13F filings with the SEC.

Stay updated on Huntington National Bank with notifications on news.